SCHEMBL7299161

SCHEMBL7299161

O=C(c1cccc(C(F)(F)F)c1)N1c2ccccc2OCC1CCCl

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.71
NPSR1 Q6W5P4 2/20 0.48
ALDH1A1 P00352 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.46
POLB P06746 2/20 0.44
GAA P10253 1/20 0.44
NR3C2 P08235 6/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CTNNB1 P35222 1/20 0.43
WNT3A P56704 1/20 0.43
NR3C1 P04150 2/20 0.42
HPGD P15428 2/20 0.42
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
RBP4 P02753 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305217 0.91 LMNA (0.72) LMNANPSR1ALDH1A1L3MBTL1POLB
SCHEMBL7302805 0.90 LMNA (0.71) LMNANPSR1ALDH1A1L3MBTL1POLB
SCHEMBL7300845 0.89 LMNA (0.58) LMNAPOLBNR3C2MEN1KMT2A
SCHEMBL7305178 0.89 LMNA (0.58) LMNAL3MBTL1POLBNR3C2MEN1
SCHEMBL8547759 0.88 LMNA (0.59) LMNANPSR1ALDH1A1L3MBTL1POLB
SCHEMBL7304570 0.86 LMNA (0.61) LMNANPSR1ALDH1A1POLBGAA
SCHEMBL7305294 0.85 LMNA (0.54) LMNAL3MBTL1POLBNR3C2MEN1
SCHEMBL7298261 0.81 LMNA (0.58) LMNAPOLBNR3C2MEN1KMT2A
SCHEMBL7299169 0.80 LMNA (0.58) LMNAL3MBTL1POLBNR3C2MEN1
SCHEMBL8548928 0.79 LMNA (0.60) LMNANPSR1ALDH1A1L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0666260-B1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1999-08-04 EP disclosed
EP-0614893-B1 Benzoxazine derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1998-05-27 EP disclosed
US-5550125-A BRAIN DISORDERS SYNTHELABO (FR) 1996-08-27 US disclosed
US-5447928-A Antiischemic agents and nervous system disorders SYNTHELABO (FR) 1995-09-05 US disclosed
EP-0666260-A1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1995-08-09 EP disclosed
EP-0614893-A1 Benzoazine derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1994-09-14 EP disclosed